» Articles » PMID: 17853477

Microglial Activation Mediates Neurodegeneration Related to Oligodendroglial Alpha-synucleinopathy: Implications for Multiple System Atrophy

Overview
Journal Mov Disord
Date 2007 Sep 14
PMID 17853477
Citations 115
Authors
Affiliations
Soon will be listed here.
Abstract

The role of microglial activation in multiple system atrophy (MSA) was investigated in a transgenic mouse model featuring oligodendroglial alpha-synuclein inclusions and loss of midbrain dopaminergic neurons by means of histopathology and morphometric analysis. Our findings demonstrate early progressive microglial activation in substantia nigra pars compacta (SNc) associated with increased expression of iNOS and correlating with dopaminergic neuronal loss. Suppression of microglial activation by early long-term minocycline treatment protected dopaminergic SNc neurons. The results suggest that oligodendroglial overexpression of alpha-synuclein may induce neuroinflammation related to nitrosive stress which is likely to contribute to neurodegeneration in MSA. Further, we detected increased toll-like receptor 4 immunoreactivity in both transgenic mice and MSA brains indicating a possible signaling pathway in MSA which needs to be further studied as a candidate target for neuroprotective interventions.

Citing Articles

Transcriptional dysregulation in the cerebellum triggered by oligodendroglial α-synucleinopathy: insights from a transgenic mouse into the early disease mechanisms of MSA.

Heras-Garvin A, Fellner L, Granata R, Wenning G, Stefanova N J Neural Transm (Vienna). 2025; .

PMID: 39954078 DOI: 10.1007/s00702-025-02892-5.


Diagnostic value and correlation analysis of serum cytokine levels in patients with multiple system atrophy.

Chen X, Chen S, Lai X, Fu J, Yang J, Ou R Front Cell Neurosci. 2024; 18:1459884.

PMID: 39295596 PMC: 11409425. DOI: 10.3389/fncel.2024.1459884.


Distinct ultrastructural phenotypes of glial and neuronal alpha-synuclein inclusions in multiple system atrophy.

Boing C, Di Fabrizio M, Burger D, Bol J, Huisman E, Rozemuller A Brain. 2024; 147(11):3727-3741.

PMID: 38696728 PMC: 11531854. DOI: 10.1093/brain/awae137.


Identification of metabolic pathways and key genes associated with atypical parkinsonism using a systems biology approach.

Pasqualotto A, da Silva V, Pellenz F, Schumacher Schuh A, Schwartz I, Siebert M Metab Brain Dis. 2024; 39(4):577-587.

PMID: 38305999 DOI: 10.1007/s11011-024-01342-7.


Relationship among α‑synuclein, aging and inflammation in Parkinson's disease (Review).

Zhang N, Yan Z, Xin H, Shao S, Xue S, Cespuglio R Exp Ther Med. 2023; 27(1):23.

PMID: 38125364 PMC: 10728906. DOI: 10.3892/etm.2023.12311.